Redrawing the Lakshman rekha
A national IPR policy, new FDI norms, a possible revamp of the Drugs & Cosmetics Act, Brexit: the pharma sector in India has a…
Author
M&As ka Side Effects
Indian pharma companies have notched up some aggressive global buys recently but the sector's experience with cross border…
‘India market is very important to us’
The number of Indian companies investing in Ireland through IDA Ireland has doubled in the last three years, from 15 companies in…
Betting big on M&As
Dr Reddy's Laboratories' June 11 announcement that it had entered into an agreement with Teva and Allergan to buy eight…
‘There will be a shakeout in the CDMO industry’
Swedish Recipharm has been on an acquisition spree, buying out Italian CDMO, Mitim Srl in February, and completing acquisition of…
Moving up the green ladder
As the Modi Government launches its second anniversary celebration on May 26, the BJP will be organising 200 odd events over a…
Chennai will house more than 60 per cent of AstraZeneca’s global IT workforce
Pharma major, AstraZeneca has set up its first insourced IT facility, The Global Technology Centre (GTC) in Chennai. David Smoley,…
IPMMA awards pharma machinery players
Seven companies were felicitated by IPMMA for '50 years of Service to Pharma Industry'
‘The companies who export must comply with the regulations of the importing country’
Sudhanshu Pandey, Joint Secretary, Department of Commerce, Ministry of Commerce & Industry, Government of India takes some…
Embracing quality as an opportunity
Concerned with declining pharma exports in the recent past, the Ministry of Commerce & Industry has tried to burnish the brand…